NERVTEX, a Chinese company focused on developing digital therapeutics for brain disorders, has obtained the approval of the China National Medical Products Administration for its AI-powered movement disorder analysis software.
Called MoDAS (Movement Dysfunction Assessment Software), the software as a medical device uses computer vision and deep learning to analyse videos of a patient's movement...
